| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.07B | +6.1% |
| R&D Expense | $884.0M | +4.0% |
| SG&A Expense | $1.39B | +3.1% |
| Operating Income | $716.6M | +23.9% |
| Pre-tax Income | $470.4M | +57.9% |
| Income Tax | -$91.4M | +23.8% |
| Net Income | $560.1M | +35.0% |
| EPS (Basic) | $9.06 | +38.3% |
| EPS (Diluted) | $8.65 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.41B | +60.2% |
| Accounts Receivable | $716.8M | +1.6% |
| Inventory | $480.4M | -19.5% |
| Current Assets | $4.63B | +34.7% |
| Total Assets | $12.01B | +5.4% |
| Current Liabilities | $1.04B | -32.4% |
| Long-term Debt | $6.11B | +6.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.40B | +27.8% |
| Capital Expenditures | $38.1M | +58.9% |
| Investing Cash Flow | -$508.2M | -211.7% |
| Financing Cash Flow | $20.5M | +106.7% |
| Free Cash Flow | $1.36B | +27.1% |
| +41.8% |
| Stockholders' Equity |
| $4.09B |
| +9.5% |